mp16-14: a phase ii trial of intravesical gemcitabine and docetaxel (gemdoce) treatment of bcg-naïve
Published 1 month ago • 64 plays • Length 2:53Download video MP4
Download video MP3
Similar videos
-
1:41
dr. harold j. burstein on cdk4/cdk6 inhibitor abemaciclib in breast cancer
-
3:01
management of atypia on core needle biopsy by barbara a. pockaj, md | preview
-
31:32
atlas and cdk4/6 inhibitor trials presented by dr. john smith ii, compass oncology
-
2:46
upfrontpsma trial: 177lu-psma-617 and docetaxel in mhnpc
-
0:47
bo-112: enhancing immune-checkpoint inhibition in solid tumors
-
1:39
phase i/ii trial of adct-602 in b-all
-
2:55
results of engot-ov16/nova phase iii trial of niraparib in platinum-sensitive ovarian cancer
-
32:26
07 immunotherapy for bladder cancer what is standard and what is the future prof m galsky
-
1:11
the mimosa trial and a novel prognostic factor in breast cancer
-
1:03
azd2014 for treating er metastatic breast cancer – mode of action and trial results
-
2:11
phase ii trial of platinum-etoposide chemotherapy & durvalumab with sbrt for small cell lung cancer
-
0:15
this is the reality of becoming a surgeon.
-
1:54
phase i/ib trial of talazoparib plus gemtuzumab ozogamicin in r/r aml
-
0:57
surpass: mechanism of action of adp-a2m4cd8
-
2:25
interferons in the treatment of mpns: clinical trials in 2021
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
2:21
180 updated phase 1 results of teclistamab, a bcma x cd3 bispecific antibody
-
0:51
ember-2: preoperative imlunestrant for er /her2- early stage breast cancer